Mucosal-Associated Invariant T Cell

Mucosal-associated invariant T (MAIT) cells are an evolutionarily conserved population of innate-like ("unconventional") T lymphocytes that bridge innate pattern recognition and adaptive T-cell cytotoxicity at mammalian mucosal surfaces, the liver, and peripheral blood. First identified as a conserved T-cell receptor (TCR) α-chain rearrangement in human blood by Steven Porcelli et al. (1993) and Florence Tilloy, Olivier Lantz, et al. (1999), named and localized to the intestinal lamina propria and restricted by the non-polymorphic MHC class I–related molecule MR1 by Emmanuel Treiner and Olivier Lantz (2003), and shown in a landmark 2012 Nature discovery by Lars Kjer-Nielsen, Alexandra J. Corbett, Jamie Rossjohn, and James McCluskey (Kjer-Nielsen et al., 2012; Corbett et al., 2014) to recognize small-molecule riboflavin (vitamin B₂) biosynthesis intermediates, MAIT cells represent 1% to 10% of all peripheral blood T cells and up to 20% to 45% of all T cells in the human liver. Rather than recognizing peptidic antigens on polymorphic HLA class I or II molecules, MAIT cells express a semi-invariant TCRα chain (Vα7.2–Jα33 in humans; Vα19–Jα33 in mice) that detects unstable pyrimidine adducts—principally 5-(2-oxopropylideneamino)-6-D-ribitylaminouracil (5-OP-RU)—synthesized exclusively by bacteria and yeasts that possess the riboflavin biosynthesis pathway, while also responding in a TCR-independent manner to IL-12 and IL-18 during viral infections and orchestrating mucosal tissue repair (Godfrey et al., 2019).

Conserved Vα7.2–Jα33 Rearrangement and Oligoclonal TCRβ Pairing

Unlike conventional MHC-restricted CD4⁺ and CD8⁺ αβ T cells—whose V(D)J recombination generates >10⁷ distinct TCR clonotypes tailored to individual HLA alleles—MAIT cells express a genetically stereotyped semi-invariant T-cell receptor:

• In Humans: The TCRα chain is formed by rearrangement of the variable gene segment TRAV1-2 (Vα7.2) joined primarily to TRAJ33 (Jα33) (or less frequently TRAJ12 or TRAJ20), producing a fixed-length 12-amino-acid complementarity-determining region 3α (CDR3α) loop containing an invariant Tyr95α residue (Tilloy et al., 1999; Reantragoon et al., 2013). This invariant α chain pairs with a highly biased subset of TCRβ chains dominated by TRBV6 (Vβ13) and TRBV20-1 (Vβ2).
• In Mice: The homologous rearrangement joins TRAV1 (Vα19) to TRAJ33 (Jα33) paired with TRBV13 (Vβ8) or TRBV19 (Vβ6).
• Surface Phenotype: Mature human MAIT cells are predominantly CD8⁺ (expressing either heterodimeric CD8αβ or homodimeric CD8αα, ~80%–85%) or double-negative (CD4⁻CD8⁻, ~10%–15%), and express uniformly high levels of the C-type lectin CD161 (KLRB1), the interleukin-18 receptor α chain (IL-18Rα / CD218a), the dipeptidyl peptidase CD26, and the multidrug efflux transporter ABCB1 (MDR1).

The Non-Polymorphic MHC Class I–Related Molecule MR1

MAIT cells are restricted across all humans and mammals by MR1 (encoded on human chromosome 1q25.3, outside the polymorphic HLA locus on chromosome 6p21; Treiner et al., 2003). MR1 is the most evolutionarily conserved MHC class I–like protein in placental and marsupial mammals, sharing ~90% amino acid identity in its α₁/α₂ antigen-binding groove between humans and mice.

In the absence of microbial ligands, newly synthesized MR1 heterodimers (complexed with β₂-microglobulin) remain retained inside the endoplasmic reticulum (ER) in a partially folded, ligand-receptive conformation stabilized by tapasin and calreticulin (McWilliam et al., 2016). Unlike classical HLA class I molecules, the MR1 A′-pocket is lined with aromatic tyrosine and tryptophan residues that form an aromatic cradle Surrounding a single nucleophilic lysine residue at position 43 (Lys43).

The ribA / ribD Pathway and Non-Enzymatic Condensation with Methylglyoxal

Mammals lack the enzymatic pathway required to synthesize riboflavin (vitamin B₂) de novo and must obtain it from the diet, whereas most pathogenic and commensal bacteria (Escherichia coli, Salmonella enterica, Klebsiella pneumoniae, Mycobacterium tuberculosis, Pseudomonas aeruginosa, Staphylococcus aureus) and fungi (Candida albicans, Saccharomyces cerevisiae, Aspergillus) synthesize riboflavin endogenously from guanosine triphosphate (GTP) via the RibA/RibD/RibH enzymatic cascade (Kjer-Nielsen et al., 2012; Corbett et al., 2014).

As proved by Alexandra J. Corbett et al. (2014) in Nature, the immediate precursor to riboflavin generated by the RibD reductase/deaminase is 5-amino-6-D-ribitylaminouracil (5-A-RU). Although 5-A-RU itself does not activate MAIT cells directly, when 5-A-RU encounters small α-dicarbonyl glycolysis byproducts derived from either microbial or host cellular metabolism—specifically methylglyoxal (pyruvaldehyde) or glyoxal—it undergoes rapid non-enzymatic condensation to form two transient, potent pyrimidine intermediates:

1. 5-(2-oxopropylideneamino)-6-D-ribitylaminouracil (5-OP-RU): Formed by condensation of 5-A-RU with methylglyoxal (dissociation constant K_d for MAIT TCR ≈ 1–2 nM, activating MAIT cells at picomolar concentrations!).
2. 5-(2-oxoethylideneamino)-6-D-ribitylaminouracil (5-OE-RU): Formed by condensation of 5-A-RU with glyoxal.

By contrast, bacteria that lack the riboflavin biosynthesis pathway—such as Enterococcus faecalis, Streptococcus pyogenes, Listeria monocytogenes, and Borrelia burgdorferi—cannot produce 5-A-RU and are invisible to the MAIT cell TCR. Conversely, photodegradation of dietary folic acid (vitamin B₉) generates 6-formylpterin (6-FP), which binds MR1 without engaging Tyr95α of the MAIT TCR, acting as a competitive antagonist (Kjer-Nielsen et al., 2012).

Covalent Schiff Base Bond with MR1 Lysine-43

In aqueous physiological buffer at 37 °C, free 5-OP-RU is chemically unstable (half-life ≈ 15 to 90 minutes), rapidly cyclizing into inactive lumazines (such as RL-6,7-diMe). However, when 5-OP-RU diffuses into the endoplasmic reticulum of an antigen-presenting cell or mucosal epithelial cell, its exocyclic carbonyl group reacts with the ε-amino group of Lys43 inside the MR1 A′-pocket to form a covalent Schiff base (imine bond) (Corbett et al., 2014; McWilliam et al., 2016). Covalent trapping of 5-OP-RU neutralizes the positive charge on Lys43, triggers full conformational folding of the MR1–β₂m heterodimer, and releases the MR1–5-OP-RU complex from the ER to traffic rapidly to the cell surface. At the plasma membrane, the conserved Tyr95α hydroxyl group of the MAIT Vα7.2–Jα33 TCR reaches directly into the MR1 cleft to form a stereo-specific hydrogen bond with the 2′-hydroxyl of the ribityl tail of 5-OP-RU!

1. TCR-Dependent Antibacterial and Antifungal Cytotoxicity (Tc17 / Th17 Profile)

Guided during thymic development by the promyelocytic leukemia zinc finger transcription factor PLZF (ZBTB16) alongside RORγt (RORC) and T-bet (TBX21), mature MAIT cells exist in a poised effector-memory state (CD45RO⁺CCR6⁺CCR5⁺). Upon engaging MR1–5-OP-RU on bacterially infected macrophages, dendritic cells, or biliary/bronchial epithelial cells, MAIT cells degranulate within hours—releasing perforin, granzyme B, and the prokaryotic membrane-disrupting protein granulysin to lyse intracellular bacteria (Mycobacterium, Shigella, Francisella, Legionella) while secreting IFN-γ, TNF-α, IL-17A, and IL-22 to recruit neutrophils and stimulate epithelial β-defensin production (Le Bourhis et al., 2010).

2. TCR-Independent Viral Sensing via IL-12, IL-18, and Type I Interferons

Even though viruses encode no enzymes and synthesize no riboflavin, MAIT cells express some of the highest densities of IL-18Rα and IL-12Rβ2 among all human lymphocytes. As demonstrated by Bonnie van Wilgenburg, Paul Klenerman, et al. (2016), during acute infections with influenza A, dengue virus, hepatitis C virus, or SARS-CoV-2, viral RNA sensing by plasmacytoid dendritic cells and monocytes triggers release of IL-12, IL-18, and IFN-α/β. This cytokine triad drives potent TCR-independent bystander activation of MAIT cells to secrete high levels of antiviral IFN-γ and granzyme B.

3. Microbiome Imprinting and Cutaneous/Mucosal Wound Repair

Using MR1–5-OP-RU tetramers in germ-free versus colonized mice, Michael G. Constantinides, Yasmine Belkaid, et al. (2019) and Timothy S. C. Hinks et al. (2019) discovered that early-life colonization by riboflavin-synthesizing commensals in the human microbiome is required for thymic egress and peripheral seeding of MAIT cells:5-OP-RU produced by neonatal gut and skin commensals diffuses across the mucosal barrier into the bloodstream and thymus to drive positive selection of Vα7.2/Vα19 thymocytes. Furthermore, when MAIT cells are stimulated via their TCR in the absence of inflammatory IL-12/IL-18, they execute a selective tissue-repair transcriptional program—secreting amphiregulin (AREG), vascular endothelial growth factor (VEGF), TGF-β, and IL-22 to accelerate re-epithelialization of intestinal ulcers and cutaneous wounds (Leng et al., 2019).

Why are MAIT cells 50- to 100-fold more abundant in humans than in standard laboratory mice?

In adult humans, MAIT cells represent 1% to 10% of peripheral blood T cells and up to 45% of hepatic T cells, whereas in clean specific-pathogen-free (SPF) C57BL/6 laboratory mice, MAIT cells account for fewer than 0.05% to 0.1% of T cells. This disparity arises both from cis-acting promoter differences in TRAV1 rearrangement frequency and from microbial exposure: when laboratory mice are colonized with wild microbiota ("rewilded" or pet-store mice) or topically exposed to Staphylococcus epidermidis and 5-OP-RU during a critical neonatal window, their peripheral MAIT cell compartments expand 10- to 50-fold (Constantinides et al., 2019).

How do MAIT cells distinguish harmless riboflavin-producing gut commensals from invasive pathogens?

Because both beneficial gut commensals (Bacteroides, Escherichia coli) and invasive pathogens (Salmonella, Mycobacterium) synthesize 5-OP-RU, a MAIT cell activated by TCR ligation alone (Signal 1, triggered by steady-state commensal 5-OP-RU diffusing across intact epithelium) does not unleash tissue-destructive cytotoxicity; instead, TCR-only signaling induces the homeostatic tissue-repair and barrier-maintenance program (amphiregulin, IL-22, VEGF). Full inflammatory licensing—marked by high-output IFN-γ, TNF-α, granzyme B, and perforin degranulation—requires co-stimulation by innate danger cytokines (IL-12, IL-18, and TLRs) that are released only when a pathogen breaches the epithelium and activates lamina propria macrophages (Hinks et al., 2019; Leng et al., 2019).

1. Treiner, E., Duban, L., Bahram, S., Radosavljevic, M., Wanner, V., Tilloy, F., et al. (2003). "Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1." Nature, 422(6928), 164–169. https://doi.org/10.1038/nature01433
2. Le Bourhis, L., Martin, E., Péguillet, I., Guihot, A., Froux, N., Coré, M., et al. (2010). "Antimicrobial activity of mucosal-associated invariant T cells." Nature Immunology, 11(8), 701–708. https://doi.org/10.1038/ni.1890
3. Kjer-Nielsen, L., Patel, O., Corbett, A. J., Le Nours, J., Meehan, B., Liu, L., et al. (2012). "MR1 presents microbial vitamin B metabolites to MAIT cells." Nature, 491(7426), 717–723. https://doi.org/10.1038/nature11605
4. Corbett, A. J., Eckle, S. B. G., Birkinshaw, R. W., Liu, L., Patel, O., Mahony, J., et al. (2014). "T-cell activation by transitory neo-antigens derived from distinct microbial pathways." Nature, 509(7500), 361–365. https://doi.org/10.1038/nature13160
5. Godfrey, D. I., Koay, H. F., McCluskey, J., & Gherardin, N. A. (2019). "The biology and functional importance of MAIT cells." Nature Immunology, 20(9), 1110–1128. https://doi.org/10.1038/s41590-019-0444-8